Chargement en cours...
Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
In a previous study, we determined that major pathologic response (MPR) as indicated by the percentage of residual viable tumor cells predicted overall survival (OS) in patients with non‐small‐cell lung cancer (NSCLC) who received neoadjuvant chemotherapy. In this study, we assessed whether two gene...
Enregistré dans:
| Publié dans: | Cancer Med |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010873/ https://ncbi.nlm.nih.gov/pubmed/29673125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1505 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|